source
- FDA pushes back decision on Capricor’s Duchenne cell therapy, GSK clears hepatitis B drug in JapanThe U.S. Food and Drug Administration has extended its review of Capricor Therapeutics' experimental Duchenne muscular dystrophy cell therapy, deramiocel. The agency moved its decision deadline fro…
- Early Alert: Nitric Oxide Delivery System Issue from NOxBOXThe NOxBOX NOxBOXi System may leak oxygen during inhaled nitric oxide therapyfda medwatch · 15h ago↗ source